These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21071432)

  • 21. Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family.
    Jørgensen A; Fagerheim T; Rand-Hendriksen S; Lunde PI; Vorren TO; Pepin MG; Leistritz DF; Byers PH
    Eur J Hum Genet; 2015 Jun; 23(6):796-802. PubMed ID: 25205403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.
    Bowen CJ; Calderón Giadrosic JF; Burger Z; Rykiel G; Davis EC; Helmers MR; Benke K; Gallo MacFarlane E; Dietz HC
    J Clin Invest; 2020 Feb; 130(2):686-698. PubMed ID: 31639107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ehlers-Danlos syndrome type IV with a novel COL3A1 exon 14 skipping variation confirmed by Tohoku Medical Megabank Organization genomic database.
    Shido K; Kojima K; Yoshida-Akai S; Kikuchi K; Hatamochi A; Aiba S; Yamasaki K
    J Dermatol; 2021 Dec; 48(12):1918-1922. PubMed ID: 34453356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful endovascular repair of acute type B aortic dissection in undiagnosed Ehlers-Danlos syndrome type IV.
    Khalique Z; Lyons OT; Clough RE; Bell RE; Reidy JF; Schwarze U; Byers PH; Taylor PR
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):608-9. PubMed ID: 19695909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1.
    Monroe GR; Harakalova M; van der Crabben SN; Majoor-Krakauer D; Bertoli-Avella AM; Moll FL; Oranen BI; Dooijes D; Vink A; Knoers NV; Maugeri A; Pals G; Nijman IJ; van Haaften G; Baas AF
    Am J Med Genet A; 2015 Jun; 167(6):1196-203. PubMed ID: 25845371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
    Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
    Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
    Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ehlers-Danlos syndrome type IV in association with a (c.970G>A) mutation in the COL3A1 gene.
    Rebelo M; Ramos L; Lima J; Vieira JD; Tavares P; Teixeira L; Matos A; Costa JN
    Acta Med Port; 2011; 24(6):1079-86. PubMed ID: 22713205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological presentation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism.
    Palmeri S; Mari F; Meloni I; Malandrini A; Ariani F; Villanova M; Pompilio A; Schwarze U; Byers PH; Renieri A
    Clin Genet; 2003 Jun; 63(6):510-5. PubMed ID: 12786757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy.
    Leistritz DF; Pepin MG; Schwarze U; Byers PH
    Genet Med; 2011 Aug; 13(8):717-22. PubMed ID: 21637106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel COL3A1 gene mutation in patient with aortic dissected aneurysm and cervical artery dissections.
    Lee ST; Kim JA; Jang SY; Kim DK; Kim JW; Ki CS
    Heart Vessels; 2008 Mar; 23(2):144-8. PubMed ID: 18389341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome.
    Plancke A; Holder-Espinasse M; Rigau V; Manouvrier S; Claustres M; Khau Van Kien P
    Eur J Hum Genet; 2009 Nov; 17(11):1411-6. PubMed ID: 19455184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation.
    Borck G; Beighton P; Wilhelm C; Kohlhase J; Kubisch C
    Am J Med Genet A; 2010 Aug; 152A(8):2090-3. PubMed ID: 20635400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
    Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
    Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development.
    Liu X; Wu H; Byrne M; Krane S; Jaenisch R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1852-6. PubMed ID: 9050868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritable diseases of the blood vessels.
    Baxter BT
    Cardiovasc Pathol; 2005; 14(4):185-8. PubMed ID: 16009316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
    Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Ehlers-Danlos syndrome presenting as rapidly progressive multiple arterial aneurysms and dissections.
    Mortani Barbosa EJ; Pyeritz RE; Litt H; Desjardins B
    Am J Med Genet A; 2011 Dec; 155A(12):3090-4. PubMed ID: 22065459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
    Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
    Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.